AbCellera

View All

pharma-news
Startup focuses tumors with CAR-T; AbCellera grabs USD 105M; Gilead inks USD 2B deal; GSK’s anti-BCMA antibody receives a boost

The startup focuses on glioblastoma tumors with CAR-T therapy. CAR-T technology that involves genetically modifying a patient’s immune cells to recognize and attack cancer. However, while the innovation has helped patients with certain blood malignancies, progress in solid tumors remains restricted. The scien...

Find More

Coronavirus
Wuhan Coronavirus: A global emergency

An outbreak of a mysterious viral infection, 2019-nCoV – coronavirus, has set the whole world on toes, claiming the lives of more than 800 people in China, surpassing the death toll caused from SARS, reports the Chinese government.  An infection with the symptoms more or less like pneumonia, known by the name ...

Find More